文献速递胃肠外科围术期管理与 ERAS

磁性括约肌增强术在食管裂孔疝患者中的临床结局与复发模式

Magnetic sphincter augmentation (MSA) in patients with hiatal hernia: clinical outcome and patterns of recurrence.
PubMed 文献 · Surg Endosc · 2019-07-08

本研究回顾性分析2013年6月至2017年8月接受磁性括约肌增强术(MSA)的350例患者,按食管裂孔疝(HH)状态分组比较结局。结果显示MSA后满意度和GERD-HRQL改善与HH存在及大小无关,但HH复发率随术前HH尺寸增大而升高,且仅PEH患者90天再入院率较高。

要点

  • MSA后满意度和GERD症状改善不依赖于HH是否存在或大小。
  • HH复发率随术前HH尺寸增大而升高(0%、10.1%、16.6%、20%)。
  • 仅食管旁疝患者90天再入院率较高,多数复发无需再次手术。

核心结论

  • MSA后优异结局和高满意度不依赖于HH的存在或大小。
  • 尽管大HH和PEH患者疝复发率较高,但术后内镜干预和装置移除率与无或小HH患者相似。
  • 应放弃MSA的最小解剖方法。

研究设计与样本

  • 回顾性 review 前瞻性收集的数据,纳入2013年6月至2017年8月接受MSA的患者。
  • 共350例患者,女性占60%,平均(SD)年龄53.5(13.8)岁。
  • 按HH状态分为四组:无HH 65例(18.6%)、小HH(<3 cm)205例(58.6%)、大HH(≥3 cm)58例(16.6%)、食管旁疝(PEH)22例(6.2%)。
  • 平均随访13.6(10.4)个月。

主要发现

  • 结局满意度各组相似:86%、87.9%、92.2%、93.8%(p=0.72)。
  • GERD-HRQL总分临床改善各组相似:79.1%、77.8%、82%、87.5%(p=0.77)。
  • 术后吞咽困难(p=0.33)和停用PPI(p=0.96)各组相似。
  • 大HH或PEH患者住院时间更长,仅PEH患者90天再入院率更高(p=0.0004)。
  • 装置移除总体5%,各组相似(p=0.28);HH复发合计10%,240例中仅7例(2.9%)需再手术。

关键数值与推荐

  • HH复发率随术前HH尺寸增大而直接相关:0%、10.1%、16.6%、20%(p=0.032)。
  • 各组术后扩张需求无差异(p=0.13)。

临床怎么用

  • MSA可考虑用于合并HH的患者,结局满意度和症状改善与无HH患者相似。
  • 大HH和PEH患者术后需关注疝复发风险,但多数复发无需再次手术。
  • 应避免MSA的最小解剖方法(不修补疝)。

局限性

  • 回顾性研究设计。
  • 平均随访时间较短(13.6个月)。
  • 单中心数据,样本量有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Magnetic sphincter augmentation (MSA) is an effective treatment for patients with gastroesophageal reflux disease. In early studies, patients with a hiatal hernia (HH) ≥ 3 cm were excluded from consideration for implantation and initially the FDA considered its use as "precautionary" in this context. This early approach has led to an attitude of hesitance among some surgeons to offer this therapy to patients with HH. This study was designed to evaluate the impact of HH status on the outcome of MSA and to report the rate of HH recurrence after MSA. METHODS AND PROCEDURES: This is a retrospective review of prospectively collected data of patients who underwent MSA between June 2013 and August 2017. Baseline clinical and objective data were collected. Patients were divided into four groups based on HH status: no HH, small HH (< 3 cm), large HH (≥ 3 cm), and paraesophageal hernia (PEH). Patient satisfaction, GERD-HRQL and RSI data, freedom from PPI, need for postoperative dilation, length of hospitalization, 90-day readmission rate, need for device removal, and HH recurrence was compared between groups. RESULTS: There were 350 patients [60% female, mean (SD) age: 53.5 (13.8)] who underwent MSA. There were 65 (18.6%) with no HH, 205 (58.6%) with small HH (< 3 cm), 58 (16.6%) with large HH (≥ 3 cm) and 22 (6.2%) with PEH. At a mean follow-up of 13.6 (10.4) months, the rate of outcome satisfaction was similar between the groups (86%, 87.9%, 92.2% and 93.8%, p = 0.72). This was also true for GERD-HRQL total score clinical improvement (79.1%, 77.8%, 82% and 87.5%, p = 0.77). The rate of postoperative dysphagia (p = 0.33) and freedom from PPIs (p = 0.96) were similar among the four groups. Duration of hospitalization was higher among those with a large HH or PEH, and only PEH patients had a higher 90-day readmission rate (p = 0.0004). There was no difference between the need for dilation among groups (p = 0.13). The need for device removal (5% overall) was similar between the four groups (p = 0.28). HH recurrence was 10% in all groups combined, and only 7 of 240 (2.9%) patients required reoperation; the majority of these patients underwent a minimal dissection approach (no hernia repair) at the index operation. The incidence of recurrent HH increased in direct correlation with the preoperative HH size (0%, 10.1%, 16.6 and 20%, p = 0.032). CONCLUSION: In the largest series of MSA implantation, we demonstrate that the excellent outcomes and high degree of satisfaction after MSA are independent of the presence or size of HH. Despite higher rates of hernia recurrence in large HH and PEH patients, the rates of postoperative endoscopic intervention, and device removal is similar to those with no or small HH. The minimal dissection approach to MSA should be abandoned.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Ayazi S, Chowdhury N, Zaidi AH, et al. Magnetic sphincter augmentation (MSA) in patients with hiatal hernia: clinical outcome and patterns of recurrence. Surg Endosc. 2019. PMID: 31286251. doi:10.1007/s00464-019-06950-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。